Dear e-druggers,
Someone recently posted about the Abbott antibiotic temafloxacin, which was
withdrawn worldwide in 1992 because of reports of severe adrs and deaths in
the US. I have been researching the drug's brief history for a chapter of a
book I'm writing on the pharmaceutical industry--about which Rizwan kindly
posted earlier--and have two questions you might be able to help me with.
1. In your country, was any regulatory action taken against Abbott for late
reporting of serious ADRs and deaths? I know British authorities were
concerned about this, and suspect that others might have been as well.
2. does anyone know a German clinical investigator named Rosch, whose studies
included two patients with ADRs with symptoms later identified as part of
what FDA called "temafloxacin syndrome"?
thanks for your help.
Stephen Fried
Philadelphia
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.